Literature DB >> 7906496

Mechanisms of action of mycophenolic acid.

A C Allison1, W J Kowalski, C D Muller, E M Eugui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7906496     DOI： 10.1111/j.1749-6632.1993.tb17143.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  24 in total

1.  A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.

Authors:  Elliot M Frohman; Gary Cutter; Gina Remington; Hongjiang Gao; Howard Rossman; Bianca Weinstock-Guttman; Jacqueline E Durfee; Amy Conger; Ellen Carl; Katherine Treadaway; Eric Lindzen; Amber Salter; Teresa C Frohman; Anjali Shah; Angela Bates; Jennifer L Cox; Michael G Dwyer; Olaf Stüve; Benjamin M Greenberg; Michael K Racke; Robert Zivadinov
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

Review 2.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

3.  Chronic allograft nephropathy and mycophenolate mofetil introduction in paediatric renal recipients.

Authors:  Larissa Kerecuk; Judy Taylor; Godfrey Clark
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

4.  A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase.

Authors:  Kehinde F Omolabi; Emmanuel A Iwuchukwu; Clement Agoni; Fisayo A Olotu; Mahmoud E S Soliman
Journal:  J Mol Model       Date:  2021-01-09       Impact factor: 1.810

5.  Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89.

Authors:  M B Faletto; W H Miller; E P Garvey; M H St Clair; S M Daluge; S S Good
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

6.  Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor- and tumour necrosis factor-receptor superfamily costimulatory molecules.

Authors:  Miranda M L Van Rijen; Herold J Metselaar; Martijn Hommes; Jan N M Ijzermans; Hugo W Tilanus; Jaap Kwekkeboom
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

Review 7.  Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.

Authors:  W D Simmons; S C Rayhill; H W Sollinger
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

8.  The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase.

Authors:  Melissanne de Wispelaere; Amy J LaCroix; Priscilla L Yang
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  Leflunomide interferes with pyrimidine nucleotide biosynthesis.

Authors:  H M Cherwinski; N Byars; S J Ballaron; G M Nakano; J M Young; J T Ransom
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

Review 10.  A review of the pharmacokinetics of abacavir.

Authors:  Geoffrey J Yuen; Steve Weller; Gary E Pakes
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.